MENUNews Archive
Date: 10/20/2021
Heavy metals like lead, industrial pollution from steel mills, coal-fired power plants or oil refineries, “forever chemicals” called PFAS that do not break down in the environment.
Date: 10/16/2021
While substantial strides have been made against some types of childhood cancers, high-grade gliomas still lack effective treatments. Thirty to 60% of these pediatric brain tumors bear mutations in the gene H3F3A.
Date: 10/08/2021
Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood brain tumor in laboratory studies, an international team of researchers led by the Rogel Cancer Center report in Science Translational Medicine.
Date: 10/07/2021
Women newly diagnosed with breast or ovarian cancer who are also carriers of cancer-associated mutations like BRCA1 or BRCA2 are no more likely to die of their tumors than those who don’t have the mutations, according to a new study.
Date: 10/04/2021
Cancer centers and/or health care systems that prioritize coordination and communication provide higher-quality end-of-life care for cancer patients who are eligible for both Medicare and Medicaid, University of Michigan researchers found.
Date: 09/30/2021
The Adolescent and Young Adult (AYA) Oncology program, established at C.S. Mott Children’s Hospital and the Rogel Cancer Center is feared toward those ages 13 to 39. The initiative is made up of physicians, social workers and researchers with expertise in adult, adolescent or pediatric medicine.
Date: 09/29/2021
A common mutation in gliomas sensitizes them to immunotherapy, a finding which researchers believe could have broader therapeutic implications for all glioma patients.
Date: 09/16/2021
President Joseph Biden named Christopher Friese, Ph.D., R.N., among seven new members of the National Cancer Advisory Board, an elite group of 18 cancer clinicians and researchers who play an important role in guiding the director of the National Cancer Institute in setting the course for the national cancer research program. Friese’s term will last six years.
Date: 09/14/2021
Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longer and go longer without their disease progressing than patients with high levels.
Date: 08/27/2021
Communication between patients and their primary care providers is key to ensuring effective cancer care, both before diagnosis and after treatment, according to two recent papers led by University of Michigan Rogel Cancer Center researchers.